Cat.#: ASSD-149
| Description | D-luciferin sodium salt, a water-soluble chemiluminescent luciferase substrate, is commonly used for in vivo and in vitro imaging of the expression of luciferase. The compound is nontoxic and stable in cells and live animals. |
| Size | 10 mg, 50 mg, 100 mg |
| Chemical Name | (4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic acid sodium salt |
| Molecule Weight | 302.3 |
| Molecular formula | C11H7N2NaO3S2 |
| CAS Number | 103404-75-7 |
| PubChem identifier | 5702588 |
| MDL Number | MFCD00044938 |
| Purity | >98% |
| Solubility | Soluble in water (100 mM), and in DMSO (100 mM) |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-122 | Fluorescent β2 antagonist [(±)-propranolol] (AC122) | 500 μg | inquiry |
| ASSD-202 | 5(6)-Carboxytetramethylrhodamine (AC202) | 100 mg, 250 mg | inquiry |
| ASSD-171 | Ionomycin calcium salt (AC171) | 1mg, 5mg | inquiry |
| ASSD-136 | LUF7445/A2A antagonist (AC136) | 50 μg | inquiry |
| ASSD-134 | FITC Phalloidin (AC134) | 300 tests, 100μg | inquiry |
| ASSD-203 | Bis(2,2′-bipyridine)-4,4′-dicarboxybipyridine-ruthenium di(N-succinimidyl ester) bis(hexafluorophosphate) (AC203) | 5 mg | inquiry |
| ASSD-223 | Antifade Fluorescence Mounting Medium (aqueous) (AC223) | 10 mL | inquiry |
| ASSD-192 | 4-Fluoro-7-nitrobenzofurazan (AC192) | 5 mg, 25 mg, 50 mg | inquiry |
| ASSD-107 | Modified Mayer's Hematoxylin (AC107) | 125 mL, 250 mL, 2×250mL | inquiry |
| ASSD-153 | Brilliant Blue G (AC153) | 1g | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.